Sensorion Announces Positive Results From SENS-218 Phase 1 Clinical Trial Undertaken in the UK

Read

Sensorion Obtains FDA Approval to Initiate a Clinical Study of SENS-111 in Acute Severe Vertigo

Read

Sensorion strengthens its financial structure with the exercise of the second tranche of its financing agreement

Read

Sensorion to Present Data from Phase 1b Clinical Trial of SENS-111 at AAO-HNSF Annual Meeting

Read

2015 Annual Results in line with the Company’s Development

Read

Pipeline

20190603 pipeline

Enregistrer

Patient center

Corporate presentation

Next events